I need Info
Will Theralase get this designation once approved?
With FDA Orphan Drug Designation (which means it gets 7 years of exclusive marketing rights once it’s approved) and Fast Track Status (which speeds up the review process because it addresses a serious unmet medical need), Tecarfarin has significant market potential due to its ability to solve key issues associated with Warfarin, including its complex metabolism and kidney-related complications.